147 related articles for article (PubMed ID: 29724767)
1. Role of the Apparent Diffusion Coefficient as a Predictor of Tumor Progression in Patients with Chordoma.
Sasaki T; Moritani T; Belay A; Capizzano AA; Sato SP; Sato Y; Kirby P; Ishitoya S; Oya A; Toda M; Takahashi K
AJNR Am J Neuroradiol; 2018 Jul; 39(7):1316-1321. PubMed ID: 29724767
[TBL] [Abstract][Full Text] [Related]
2. Apparent diffusion coefficient as a prognostic factor in clival chordoma.
Oh HC; Hong CK; Lee KS; Cha YJ; Ahn SJ; Suh SH; Park HH
Sci Rep; 2021 Jan; 11(1):486. PubMed ID: 33436803
[TBL] [Abstract][Full Text] [Related]
3. Diagnostic accuracy of DW MR imaging in the differentiation of chordomas and chondrosarcomas of the skull base: A 3.0-T MRI study of 105 cases.
Welzel T; Meyerhof E; Uhl M; Huang K; von Deimling A; Herfarth K; Debus J
Eur J Radiol; 2018 Aug; 105():119-124. PubMed ID: 30017267
[TBL] [Abstract][Full Text] [Related]
4. Differentiating skull base chordomas and invasive pituitary adenomas with conventional MRI.
Gao A; Bai J; Cheng J; Cheng X; Li S; Zhang Z; Zhang Y
Acta Radiol; 2018 Nov; 59(11):1358-1364. PubMed ID: 29448805
[TBL] [Abstract][Full Text] [Related]
5. Pre-treatment MRI minimum apparent diffusion coefficient value is a potential prognostic imaging biomarker in cervical cancer patients treated with definitive chemoradiation.
Marconi DG; Fregnani JH; Rossini RR; Netto AK; Lucchesi FR; Tsunoda AT; Kamrava M
BMC Cancer; 2016 Jul; 16():556. PubMed ID: 27469349
[TBL] [Abstract][Full Text] [Related]
6. Predictive role of Apparent Diffusion Coefficient (ADC) from Diffusion Weighted MRI in patients with sacral chordoma treated with carbon ion radiotherapy (CIRT) alone.
Preda L; Casale S; Fanizza M; Fiore MR; Viselner G; Paganelli C; Buizza G; Fontana G; Vitolo V; Barcellini A; Baroni G; Fossati P; Valvo F
Eur J Radiol; 2020 May; 126():108933. PubMed ID: 32171109
[TBL] [Abstract][Full Text] [Related]
7. Diffusion-weighted MRI: distinction of skull base chordoma from chondrosarcoma.
Yeom KW; Lober RM; Mobley BC; Harsh G; Vogel H; Allagio R; Pearson M; Edwards MS; Fischbein NJ
AJNR Am J Neuroradiol; 2013 May; 34(5):1056-61, S1. PubMed ID: 23124635
[TBL] [Abstract][Full Text] [Related]
8. Hepatocellular Carcinoma: In Vivo Evaluation of Water Percentage as a Prognostic Biomarker Using Magnetic Resonance Imaging 3D-VIBE Multiecho Dixon.
Wang M; Yuan F; Wei Y; Xia C; Hu F; Song B
Cancer Biother Radiopharm; 2018 Sep; 33(7):300-306. PubMed ID: 30109954
[TBL] [Abstract][Full Text] [Related]
9. Diffusion Weighted Imaging for Differentiating Benign from Malignant Orbital Tumors: Diagnostic Performance of the Apparent Diffusion Coefficient Based on Region of Interest Selection Method.
Xu XQ; Hu H; Su GY; Liu H; Shi HB; Wu FY
Korean J Radiol; 2016; 17(5):650-6. PubMed ID: 27587953
[TBL] [Abstract][Full Text] [Related]
10. Chemical-shift and diffusion-weighted magnetic resonance imaging of thymus in myasthenia gravis: usefulness of quantitative assessment.
Priola AM; Priola SM; Giraudo MT; Gned D; Giardino R; Marci V; Errico L; Veltri A
Invest Radiol; 2015 Apr; 50(4):228-38. PubMed ID: 25478741
[TBL] [Abstract][Full Text] [Related]
11. Prediction of recurrence in solid nonfunctioning pituitary macroadenomas: additional benefits of diffusion-weighted MR imaging.
Ko CC; Chen TY; Lim SW; Kuo YT; Wu TC; Chen JH
J Neurosurg; 2019 Feb; 132(2):351-359. PubMed ID: 30717054
[TBL] [Abstract][Full Text] [Related]
12. Malignant astrocytic tumors: clinical importance of apparent diffusion coefficient in prediction of grade and prognosis.
Higano S; Yun X; Kumabe T; Watanabe M; Mugikura S; Umetsu A; Sato A; Yamada T; Takahashi S
Radiology; 2006 Dec; 241(3):839-46. PubMed ID: 17032910
[TBL] [Abstract][Full Text] [Related]
13. Diffusion-weighted magnetic resonance imaging of thymoma: ability of the Apparent Diffusion Coefficient in predicting the World Health Organization (WHO) classification and the Masaoka-Koga staging system and its prognostic significance on disease-free survival.
Priola AM; Priola SM; Giraudo MT; Gned D; Fornari A; Ferrero B; Ducco L; Veltri A
Eur Radiol; 2016 Jul; 26(7):2126-38. PubMed ID: 26427698
[TBL] [Abstract][Full Text] [Related]
14. Is there a role for conventional MRI and MR diffusion-weighted imaging for distinction of skull base chordoma and chondrosarcoma?
Müller U; Kubik-Huch RA; Ares C; Hug EB; Löw R; Valavanis A; Ahlhelm FJ
Acta Radiol; 2016 Feb; 57(2):225-32. PubMed ID: 25722460
[TBL] [Abstract][Full Text] [Related]
15. Apparent diffusion coefficient (ADC) measurement in ovarian tumor: Effect of region-of-interest methods on ADC values and diagnostic ability.
Mukuda N; Fujii S; Inoue C; Fukunaga T; Tanabe Y; Itamochi H; Ogawa T
J Magn Reson Imaging; 2016 Mar; 43(3):720-5. PubMed ID: 26201495
[TBL] [Abstract][Full Text] [Related]
16. Risk stratification of ductal carcinoma in situ using whole-lesion histogram analysis of the apparent diffusion coefficient.
Kim JY; Kim JJ; Lee JW; Lee NK; Lee G; Kang T; Park H; Son YH; Grimm R
Eur Radiol; 2019 Feb; 29(2):485-493. PubMed ID: 30073498
[TBL] [Abstract][Full Text] [Related]
17. The role of apparent diffusion coefficient as a predictive factor for tumor recurrence in patients with cerebellopontine angle epidermoid tumor.
Oh HC; Hong CK; Yoo J; Lee KS; Cha YJ; Ahn SJ; Suh SH; Park HH
Neurosurg Rev; 2022 Apr; 45(2):1383-1392. PubMed ID: 34581893
[TBL] [Abstract][Full Text] [Related]
18. Correlations between the minimum and mean apparent diffusion coefficient values of hepatocellular carcinoma and tumor grade.
Li X; Zhang K; Shi Y; Wang F; Meng X
J Magn Reson Imaging; 2016 Dec; 44(6):1442-1447. PubMed ID: 27228086
[TBL] [Abstract][Full Text] [Related]
19. ADC histogram analysis for adrenal tumor histogram analysis of apparent diffusion coefficient in differentiating adrenal adenoma from pheochromocytoma.
Umanodan T; Fukukura Y; Kumagae Y; Shindo T; Nakajo M; Takumi K; Nakajo M; Hakamada H; Umanodan A; Yoshiura T
J Magn Reson Imaging; 2017 Apr; 45(4):1195-1203. PubMed ID: 27571307
[TBL] [Abstract][Full Text] [Related]
20. A prospective study on the utility of diffusion-weighted and quantitative chemical-shift magnetic resonance imaging in the distinction of adrenal adenomas and metastases.
Halefoglu AM; Altun I; Disli C; Ulusay SM; Ozel BD; Basak M
J Comput Assist Tomogr; 2012; 36(4):367-74. PubMed ID: 22805662
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]
